Lincoff AM, Brown-Frandsen K, Colhoun HM, et al
7 FDA approval has sparked significant interest and investment in the weight loss drug market
late 2027 at the earliest, and more likely 2028
Through its interaction with actin, Thymosin Beta 4 facilitates cellular movements and orchestrates the repair of damaged tissues, making it a promising therapeutic agent for various conditions
The resin-bound protein was washed successively with Buffer A and finally eluted with the elution buffer containing a gradient increase in the concentration of Imidazole (50 mM Tris-HCL, pH 7.5, 500 mM NaCl and 50 mM/100 mM/250 mM Imidazole)
Tingling, numbness, or prickling have been reported in retatrutide trials and appear to increase at higher doses